Saturday, October 1, 2022


Biotechnology News Magazine

DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

DCN Dx, a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests, today announced it has completed its acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, Oregon.

Biomed has an established history of developing tools for the surveillance of microorganisms that lead to infectious diseases in humans and animals. Originally developed for use in low-resource settings, these tools are now recognized around the world for their utility, ease of use, and accuracy.

“Biomed has a strong presence in microbiological testing for veterinary, human, food safety and environmental markets, and has developed innovative solutions that combine specimen collection, culture and transport in a single device,” said Charlie Mamrak, DCN Dx’s CEO. “The portfolio of novel testing and sampling products is a perfect adjacency for DCN Dx’s core business of point-of-use test development. We’re excited to integrate Biomed’s capabilities into our own as we provide world-class solutions to our clients.”

New Products

Biomed brings a number of products to DCN Dx’s stable, including:

  • InPouch TF®, a simple-to-use culture media for the detection of the parasite that causes bovine trichomoniasis
  • TF Transit Tube, a self-contained system for the collection and transport of Tritrichomonas foetus from bovine preputial or vaginal samples
  • InPouch® TV, a self-contained broth media device for the recovery and detection of Trichnomonas vaginalis from human female vaginal samples or male urethra/urine samples
  • Transport Media (VTM) for SARS-CoV-2 sample transport
  • The INTRAY® VS COLOREXTM product line for convenient testing for microbes including MRSA and other resistant bacteria

About DCN Dx
CN Dx is a global leader in the end-to-end development, manufacture, and commercialization of point-of-use tests. From its headquarters in Carlsbad, California, DCN Dx’s cross-functional team of scientists and engineers develop and integrate all aspects of assays into reliable systems for point-of-use applications that enable users to monitor sample quality, identify pathogens, and facilitate the delivery of treatments. DCN Dx partners with industry leaders to develop point-of-use tests, train users in diagnostic development, and carry out clinical research for medical point-of-care testing, veterinary diagnostics, soil and water testing, bioprocessing, food safety, force protection, and more.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine